Top Oncology Ablation Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Oncology Ablation Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Oncology Ablation industry players.

Oncology Ablation Market Competitive Landscape

Global Oncology Ablation Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.

Top Players in Oncology Ablation Market

  • Angiodynamics (Covidien) (US) 
  • Boston Scientific Corporation (US) 
  • Medtronic Plc (US) 
  • Ethicon, Inc. (US) 
  • Galil Medical Inc. (US) 
  • Misonix Inc. (US) 
  • HealthTronics (US) 
  • Mermaid Medical (Denmark) 
  • Theraclion (France) 
  • Chongqing Haifu Medical Technology Co., Ltd. (China) 
  • HS Hospital Service S.P.A (Italy) 
  • Hologic, Inc. (US) 
  • Varian Medical Systems (US) 
  • Cook Medical (US) 
  • LeVeen Medical (US) 
  • Integra LifeSciences (US) 
  • MedWaves, Inc. (US) 
  • Sanarus Technologies, Inc. (US) 
  • Bovie Medical Corporation (US) 
  • ThermoLife (US)

Oncology Ablation Market

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Oncology Ablation Market size was valued at USD 1.32 billion in 2023 and is poised to grow from USD 1.5 billion in 2024 to USD 4.16 billion by 2032, growing at a CAGR of 13.6% during the forecast period (2025-2032).

Global Oncology Ablation Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Angiodynamics (Covidien) (US) ', 'Boston Scientific Corporation (US) ', 'Medtronic Plc (US) ', 'Ethicon, Inc. (US) ', 'Galil Medical Inc. (US) ', 'Misonix Inc. (US) ', 'HealthTronics (US) ', 'Mermaid Medical (Denmark) ', 'Theraclion (France) ', 'Chongqing Haifu Medical Technology Co., Ltd. (China) ', 'HS Hospital Service S.P.A (Italy) ', 'Hologic, Inc. (US) ', 'Varian Medical Systems (US) ', 'Cook Medical (US) ', 'LeVeen Medical (US) ', 'Integra LifeSciences (US) ', 'MedWaves, Inc. (US) ', 'Sanarus Technologies, Inc. (US) ', 'Bovie Medical Corporation (US) ', 'ThermoLife (US)'

The demand for advanced tumour ablation techniques is anticipated to increase throughout the forecast period as surgeons and patients become more inclined toward minimally invasive procedures due to the advantages of quick recovery, patient comfort, and shorter recovery times.

Cooled Radiofrequency Probes Gaining Traction: Market player are focusing on technological advancements to improve accuracy, portability, and cost-effectiveness. HIFU, cryoablation, and image-guided equipment are three prominent examples of these technological developments. One of the upcoming approaches that is projected to significantly contribute to market growth is the use of the cooled radiofrequency denervation technique with internally cooled radiofrequency probes to increase the size of the lesion. This procedure makes it possible to completely denervate the sacroiliac joint, which aids in the treatment of pain.

North America dominated the global market with a revenue share of over 30.1% in 2021. Government support for high-quality healthcare, high purchasing power parity, the availability of reimbursements, and the rising incidence of cancer are some of the main drivers of this region’s growth. The Patient Protection and Affordable Care Act (PPACA), for instance, lowers the cost of healthcare for both individuals and the government in the United States by promoting the quality and accessibility of healthcare through health coverage policies. Another important growing component is the precision medicine project, which develops personalised solutions for particular illness characteristics. Therefore, it is projected that such government initiatives will enhance the healthcare system as a whole, thereby spurring market growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Tumor Ablation Market
Buy Now GET FREE SAMPLE
Ablation Devices Market
Buy Now GET FREE SAMPLE
Cardiac Ablation Market
Buy Now GET FREE SAMPLE
Oncology Market
Buy Now GET FREE SAMPLE
Oncology Drugs Market
Buy Now GET FREE SAMPLE
Endometrial Ablation Market
Buy Now GET FREE SAMPLE
MRI-Guided Neurosurgical Ablation Market
Buy Now GET FREE SAMPLE
Cancer Biological Therapy Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Oncology Ablation Market
Oncology Ablation Market

Report ID: SQSG35B2038

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE